Financials CLEN EARTPAR

Equities

CLIN

US1844931048

Market Closed - Nasdaq 21:30:00 31/05/2024 BST 5-day change 1st Jan Change
0.4299 USD +11.37% Intraday chart for CLEN EARTPAR +4.37% -91.40%

Valuation

Fiscal Period: December 2022
Capitalization 1 318.7
Enterprise Value (EV) 1 318.9
P/E ratio 5,319 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF -1,382,151 x
FCF Yield -0%
Price to Book -46 x
Nbr of stocks (in thousands) 31,557
Reference price 2 10.10
Announcement Date 30/03/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022
Net sales - -
EBITDA - -
EBIT 1 -0.002546 -2.077
Operating Margin - -
Earnings before Tax (EBT) 1 -0.002546 0.7077
Net income 1 -0.002546 0.06
Net margin - -
EPS - 0.001899
Free Cash Flow - -230.7
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 09/02/22 30/03/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022
Net Debt 1 0.09 0.18
Net Cash position 1 - -
Leverage (Debt/EBITDA) - -
Free Cash Flow - -231
ROE (net income / shareholders' equity) - -1.74%
ROA (Net income/ Total Assets) - -1.09%
Assets 1 - -5.478
Book Value Per Share 2 0 -0.2200
Cash Flow per Share 2 0.0100 0.0200
Capex - -
Capex / Sales - -
Announcement Date 09/02/22 30/03/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. CLIN Stock
  4. Financials CLEN EARTPAR